|
Vogelzang, P J; Bloom, S M; Mier, J W et al. (1992) Chest roentgenographic abnormalities in IL-2 recipients. Incidence and correlation with clinical parameters. Chest 101:746-52
|
|
Mier, J W; Vachino, G; Klempner, M S et al. (1990) Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethasone: prevention of an acquired neutrophil chemotaxis defect and differential suppression of interleukin-2-associated side effects. Blood 76:1933-40
|
|
Aronson, F R; Libby, P; Brandon, E P et al. (1988) IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury. J Immunol 141:158-63
|
|
Mier, J W; Aronson, F R; Numerof, R P et al. (1988) Toxicity of immunotherapy with interleukin-2 and lymphokine-activated killer cells. Pathol Immunopathol Res 7:459-76
|
|
Mier, J W; Vachino, G; van der Meer, J W et al. (1988) Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients. J Clin Immunol 8:426-36
|
|
Numerof, R P; Aronson, F R; Mier, J W (1988) IL-2 stimulates the production of IL-1 alpha and IL-1 beta by human peripheral blood mononuclear cells. J Immunol 141:4250-7
|
|
Atkins, M B; Mier, J W; Parkinson, D R et al. (1988) Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med 318:1557-63
|
|
Mier, J W; Dinarello, C A; Atkins, M B et al. (1987) Regulation of hepatic acute phase protein synthesis by products of interleukin 2 (IL 2)-stimulated human peripheral blood mononuclear cells. J Immunol 139:1268-72
|
|
Atkins, M B; Gould, J A; Allegretta, M et al. (1986) Phase I evaluation of recombinant interleukin-2 in patients with advanced malignant disease. J Clin Oncol 4:1380-91
|
|
Dinarello, C A; Cannon, J G; Mier, J W et al. (1986) Multiple biological activities of human recombinant interleukin 1. J Clin Invest 77:1734-9
|
Showing the most recent 10 out of 11 publications
